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Protein turnovera b s t r a c t
Cyclin Y, a membrane associated cyclin, is capable of binding and activating CDK14. Here we report
that human cyclin Y (CCNY) is a phosphoprotein in vivo and that phosphorylation of CCNY by CDK14
triggers its ubiquitination and degradation. Inactivation of either CDK14 or Cul1 results in accumu-
lation of CCNY. An in vivo and in vitro mapping of CCNY phosphorylation sites by mass spectrometry
revealed that the ﬂanking regions of the conserved cyclin box are heavily phosphorylated. Phos-
phorylation of CCNY at Serines 71 and 73 creates a putative phospho-degron that controls its asso-
ciation with an SCF complex. Mutation of serine to alanine at these two sites stabilized CCNY and
enhanced the activity of CCNY/CDK14 on phosphorylation of LRP6. Our results provide insight into
autoregulation of the cyclin Y/CDK14 pair in CDK14 activation and cyclin Y turnover which is a pro-
cess that is involved in membrane proximal signaling.
Structured summary of protein interactions:
CCNY physically interacts with CUL1 by anti tag coimmunoprecipitation (1, 2, 3)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cyclins belong to a superfamily of eukaryotic proteins that play
a critical role in activating a group of serine/threonine kinases
called cyclin-dependent kinase (CDKs). Cyclin Y is a recently char-
acterized member of the cyclin family. It is highly conserved
among eumetazoan species [1]. In Drosophila, cyclin Y (CycY) is
proved to be essential to many stages of development, from
embryogenesis to adult life [2]. It is also reported to be required
for maximal phosphorylation of LRP6 on Ser 1490 and activation
of Wnt signaling [3]. In Xenopus embryos, cyclin Y (CycY) is
required for Wnt-dependent anteroposterior embryonic patterning
[3]. In Caenorhabditis elegans, cyclin Y (CYY-1) is required for tar-
geting of presynaptic components and regulation of synapse elim-
ination [4,5]. The functions of cyclin Y (CCNY) in mice and humans
are poorly understood, although several CCNY isoforms and CCNY-
like proteins have been detected and predicted.
CDKs are involved in the regulation of many different cellular
processes over very different time scales, including cell cycle regu-
lation (CDKs 1–4, and 6), transcription (CDKs 7–10), translation
(CDKs 1 and 11), mRNA processing (CDKs 10–13), and differentia-tion and function of neurons (CDK5) [1,6,7]. Human CDKs have
been classiﬁed as CDKs 1–20. Two of them, CDK14 (PFTK1) and
CDK16 (PCTK1), have been shown to be activated by cyclin Y [8–
10]. The CDK14 can be recruited to the plasma membrane by cyclin
Y because of its N-terminal myristoylation signal [9]. Upon recruit-
ment, it can then phosphorylate LRP6, a transmembrane receptor
that initiates Wnt/b-catenin signaling [3]. The ﬁnding that cyclin
Y/CDK14 signals through the Wnt pathway provides a promising
clue that can be used to study the regulation of this poorly charac-
terized cyclin/CDK pair.
Regulated cyclin synthesis and proteolysis are important means
of regulating the activities of some CDKs [11–13]. All known cyc-
lins are targeted for degradation by the ubiquitin–proteasome
pathway, and two families of E3 ligases are mainly involved: the
Skp/cullin/F-box-containing (SCF) complex and anaphase-promot-
ing complex/cyclosome (APC/C) [14–16]. The SCF complex is com-
posed of four subunits, Skp1, Cul1, and Rbx1 (also known as Roc1
or Hrt1), which are the invariable components, and an F-box pro-
tein, which is a variable component [17]. Cul1 serves as a scaffold
and F-box protein (phosphate-binding protein) is responsible for
substrate speciﬁcity, guiding the degradation of various sets of
substrates. The SCF-type ubiquitin ligase complex usually
contributes to ubiquitination of proteins that are marked by
phosphorylation at speciﬁc sequences known as phospho-degrons.
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(b-transducin repeat-containing protein) is DpSGXXpS [18]. Three
or more residues are found between the two phosphorylated
serines in a canonical phospho-degron, whereas, less residues are
also found in some other phospho-degrons. In the case of YAP,
there are only two residues between two serines (S384 and
S387). S387 phosphorylation is important for YAP-b-TRCP binding
[19]. Cyclins D and E are well known targets of the SCF complex:
phosphorylation of cyclin D1 on Thr 286 by GSK3 allows binding
to SCFFBX4/aB-crystallin ligase [20,21]; phosphorylation of cyclin E
on Thr 380 by GSK3b triggers recognition by SCFFbw7 [22–24].
Unlike conventional cyclins, cyclin Y contains only a single
cyclin fold [1,25], which is required for cyclin Y binding to
CDK14 and CDK16 [8]. Apart from its membrane-localization med-
iated by myristoylation at N-terminal Gly-2, the role of the ﬂanking
regions outside of the cyclin-box of cyclin Y is unclear. In the pres-
ent study, the long N- and/or C-terminal extensions of the human
cyclin Y (CCNY) were found to be heavily phosphorylated in both a
CDK14-dependent and -independent manner. The phosphorylation
of CCNY by CDK14 triggered CCNY degradation mediated by the
SCF complex. These data may add a new layer to the understanding
of the manner in which cyclin Y is regulated.2. Materials and methods
2.1. Plasmid construction
For overexpression studies, human CDK14 ORF (GenBank No.
AF119833) was cloned into the vector pEGFPN3 (Clontech). Human
CCNY ORF was cloned into the vector pMYCN3, where a C-terminal
Myc-tag was fused to CCNY [26]. The full-length human CUL1
cDNA or the 1–1356 bp fragment was cloned into vector
pcDNA3.1-N-Flag for expression of wild-type Flag-Cul1 and Flag-
DNCul1, respectively. For the kinase assay, recombinant fusionFig. 1. Determination of the phosphorylation states and sites of CCNY in vivo. (A) Immun
arrested at the indicated phases of the cell cycle by drug treatment, cell lysates were blot
lanes. (B) Mobility shift of the endogenous CCNY caused by phosphorylation. HepG2 ce
30 min before IB. Temp.: Incubation Temperature; kPP: Lambda Protein Phosphatase; Pho
cell cycle. HEK-293T cells transfected with CCNY-Myc were arrested at the indicated phas
of CCNY phosphorylation. (D) Immunoblotting analysis of CCNY-Myc in the presence or ab
was transfected alone or together with CDK14-GFP in HEK-293T cells. Cells were treated w
PAGE. (F) Identiﬁcation of phosphorylation sites on CCNY-Myc by mass spectrometry a
transfected alone; an arrow (") beneath represents phosphorylated residues when CCNYGST-CDK14 was cloned into vector pcDNA3.1. Site-directed
mutagenesis of CCNY and CDK14 was achieved by PCR ampliﬁca-
tion using Mutagenesis kit (Strategene).
2.2. Cell synchronization and ﬂuorescence-activated cell sorting
analysis (FACS)
To obtain synchronized G1/S, S or G2/M phase cells, cells were
treated with Aphidicolin or Nocodazole as described previously
[3]. Cell cycle distribution of cells was veriﬁed by ﬂow cytometry
assay following Propidium iodide (PI) staining. In brief, trypsin-
digested cells were suspended in 70% cold alcohol and kept at
4 C for 30 min. The ﬁxed cells were then treated with 1 mg/ml
of DNase-free RNase and 50 lg/ml of PI (Sigma) for 30 min at
37 C, and then analyzed on a FACSCalibur (BD). Data were ana-
lyzed with Flowjo software.
2.3. Immunoblotting (IB) and Immunoprecipitation (IP) analyses
Cell lysates were prepared with 1%-Triton lysis buffer (50 mM
Tris pH 7.5, 150 mM NaCl, 1% TritonX-100, 1 mM EDTA, complete
EDTA-free protease inhibitor cocktail (Roche) and PhosSTOP Phos-
phatase Inhibitor (Roche)). Antibodies used in this study were:
FLAG (Sigma, A2220); c-MYC (Sigma, C3956); GFP (Roche, 1181
4460001); alpha-tubulin (Abcam, ab4074); HA (Sigma, H3663);
phosphoserine (Abcam, ab9332); LRP6 (CST, 2560); LRP6
(Ser1490) (CST, 2568); cullin1 (Santa Cruz, SC-17775). Polyclonal
antibody against human CCNY and CDK14 was derived from rabbit
using conventional methods [9].
2.4. Protein degradation assay
CCNY protein degradation was assayed by Cycloheximide
(CHX)-chase analysis [27]. HepG2 cells infected with the indicated
lentivirus or HEK-293T cells transfected with the indicatedoblotting (IB) of endogenous CCNY proteins during the cell cycle. HepG2 cells were
ted with anti-CCNY antibody. FACS analysis of cells is shown beneath corresponding
lls were arrested at G2/M phase. Whole-cell extracts were treated as indicated for
sSTOP: Phosphatase Inhibitor Cocktail. (C) Phosphorylation of CCNY-Myc during the
es of the cell cycle. Anti-Myc immunoprecipitates were subjected to IB for detection
sence of ectopic CDK14-GFP. (E) Immunoprecipitation (IP) of CCNY-Myc. CCNY-Myc
ith MG132 before harvesting. Anti-Myc immunoprecipitates were resolved on SDS–
nalysis. An asterisk (⁄) above represents phosphorylated residues when CCNY was
was co-transfected with CDK14. Shaded residues represent the cyclin box of CCNY.
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another 24 h, cells were treated with 25 lg/ml CHX and then col-
lected at the indicated time points. CCNY protein abundance was
detected via Western blot. In order to calculate the CCNY protein
abundance accurately, whole-cell extracts were pretreated with
lambda protein phosphatase to avoid the mobility shift of CCNY
in the gel run. The Western blotting data were analyzed with Multi
Gauge V3.0. CCNY band intensities were quantiﬁed and normalized
to tubulin, then normalized to the t = 0 controls and used for data
statistical analysis by Sigmaplot12.
2.5. Immunoprecipitation kinase assay
In vitro kinase assay was carried out as described previously
[28]. Recombinant GST-CCNY fusion protein was expressed and
puriﬁed in Escherichia coli. GST-CDK14 was transfected in HEK-
293T cells and puriﬁed by using Glutathione Sepharose 4B in EBC
buffer (50 mM Tris pH 8.0, 120 mM NaCl, 0.25% Nonidet P-40,
100 mM NaF, 0.2 mM sodium orthovanadate, 50 lg/ml phenyl-
methylsulfonyl ﬂuoride, 10 lg/ml aprotinin, 5 mg/ml leupeptin).
Kinase reactions were performed in 30 ll protein kinase buffer
(50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 10 mM b-glycer-Fig. 2. CDK14 regulates CCNY protein stability. (A) shRNA lentivirus-mediated
knockdown of CDK14 in HepG2 cells. Lentivirus expressing blank vector or
scrambled shRNA was used as a negative control. At 72 h post-infection, total
RNAs were extracted and reverse transcribed for qRT-PCR analysis. (B) Knocking-
down of CDK14 resulted in increased CCNY protein level. Whole-cell extracts were
treated with kPP before IB. (C) Knocking-down of CDK14 increased CCNY stability.
HepG2 cells were infected with lentivirus expressing scrambled shRNA or CDK14-
targeting shRNA-3. At 72 h post-infection, cells were subjected to CHX-chase assay,
which were performed as described in experimental procedures. CCNY protein level
was analyzed by immunoblotting with anti-CCNY antibody (up panels), the band
intensity was quantiﬁed and normalized to tubulin, then normalized to the t = 0
controls and analyzed by Sigmaplot12 (down panels).ophosphate, 0.4 mM sodium orthovanadate, 5 mg/ml leupeptin)
containing 200 lM ATP and 0.5 lg of GST-CCNY for 40 min at
30 C. Reactions were stopped by the addition of SDS–PAGE load-
ing buffer and then resolved on SDS–PAGE.
2.6. Mass spectrometry (MS) analysis
The products from the in vivo and in vitro kinase assays were
fractionated by SDS–PAGE and stained with Coomassie. Gel bands
containing CCNY proteins were trypsin-digested and then analyzed
by LC-MS/MS mass spectrometry (LTQ Orbitrap Elite, Thermo Sci-
entiﬁc) [29]. The fragment ions observed in the mass spectra were
analyzed by Mascot. The MS analysis was performed by the Labo-
ratory of Mass Spectrometry, Shanghai Institute of Materia Medica,
Chinese Academy of Sciences.
2.7. RNA interference
Knockdown of CDK14 was achieved by infection of HepG2 cells
with short hairpin RNA (shRNA) lentivirus. Three sets of shRNA tar-
geting human CDK14 were designed and inserted into lentiviral
vector pLKO.1-GFP for lentivirus packaging [30]. The sequences
of shRNAs were: 1, GGGTGCATTCTGAGAACAATG; 2, GGAGTTAAAG
CTGGCAGATTT; 3, GGAAGTTGGTAGCTCTGAAGG. Scrambled
shRNA (GCGCGATAGCGCTAATAATTT) or pLKO.1-GFP empty vector
was used as a control.
Knockdown of human Cullin1 in HEK-293T cells was achieved
by transfection of small interfering RNA (siRNA). The siRNA oligos
against Cullin1 have been described previously [31]. The sequence
of control siRNA was: UUCUCCGAACGUGUCACGUTT.
2.8. qRT-PCR analyses
At 72 h after viral infection, total RNA was extracted and reverse
transcribed for qRT-PCR analysis. GAPDH was used as an internal
control. The relative expression level of mRNA was calculated by
the DDCt method. The sequences of the primers used in this study
were as follows: CCNY F & R (CCAGCACAATATTCCTCAGT and CTAA
GAGCATCCTTCCATCT). CDK14 F & R (GCTGCAGGAAGAAGAAGG
and CAACTTCACATTATCTGGATG). GAPDH F & R (CGACCACTTTGTC
AAGCTCA and AGGGGAGATTCAGTGTGGTG).3. Results
3.1. CCNY is hyper-phosphorylated in vivo
To examine the level and status of endogenous CCNY protein, we
performed Western blotting analysis in HepG2 cells, an HCC cell
line with high CCNY expression level [9], using an anti-CCNY anti-
body. We noticed the presence of slow-migration bands of CCNY,
especially in cells synchronized in G2/M phase (Fig. 1A). The treat-
ment with lambda protein phosphatase (kPP) at 30 C restored the
migration pattern of CCNY in SDS–PAGE, whereas incubation either
in the presence of the phosphatase inhibitor or at 4 C had no effect
(Fig. 1B). These observations suggest CCNY phosphorylation in vivo.
The slow-migration bands were also observed in HEK-293T cells
ectopically expressing CCNY-Myc, and phosphorylation of the
CCNY-Myc was enhanced during the G2 and M phases of the cell
cycle (Fig. 1C). Furthermore, co-expression of CDK14-GFP markedly
increased the proportion of phosphorylated CCNY-Myc present
(Fig. 1D), suggesting the importance of CDK14 in CCNY
phosphorylation.
To identify the phosphorylation sites, CCNY-Myc protein,
expressed either alone or together with CDK14-GFP, was immuno-
precipitated and further analyzed by mass spectroscopy (MS)
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Thr-67, Ser-73, Thr-75, Ser-99, Ser-100, Ser-102, Ser-288, Ser-326,
and Thr-331 was detected in cells that expressed CCNY-Myc alone,
whereas seven additional phosphorylation sites at Thr-30, Ser-33,
Thr-37, Ser-71, Ser-83, Ser-295, and Ser-324were examined in cells
co-expressing CDK14-GFP (Fig. 1F). All of the phosphorylation sites
were located at the N- or C-terminal extensions outside of the con-
served cyclin box, and none of these sites was found inside the
cyclin box. These data conﬁrmed that the CCNY is heavily
phosphorylated in vivo and that CDK14 contributes to CCNY
phosphorylation.
3.2. Knock-down of CDK14 in HepG2 cells stabilizes CCNY protein
To investigate the biological signiﬁcance of the CDK14-
dependent phosphorylation of CCNY, endogenous CDK14 was
knocked down in HepG2 cells by shRNA lentivirus. Three sets of
lentiviruses that expressed different CDK14-targeting shRNAs
were packaged and used to infect HepG2 cells (Fig. 2A). Knock-
down of CDK14 had little effect on the level of CCNY mRNA
(Fig. 2A), while CCNY protein was signiﬁcantly up-regulated
(Fig. 2B). CCNY protein turnover was examined using CHX (cyclo-
heximide)-chase analysis, and we found that the half-life of CCNY
protein was extended from 40 min to 4 h upon knock-down of
CDK14 (Fig. 2C). Therefore, down-regulation of CDK14 stabilized
the CCNY protein.
3.3. Ectopic expression of CDK14 promotes CCNY protein turnover
Since ectopically expressed CDK14 can enhance CCNY phos-
phorylation, we then investigated whether the CDK14-driven
phosphorylation of CCNY could trigger the destabilization of CCNY.
A CDK14 kinase-defective mutant was generated by replacing an
aspartate residue at 256, a putative serine/threonine protein kinase
active site, with alanine. Compared with the wild-type CDK14,Fig. 3. Over-expression of CDK14 stimulates CCNY degradation via the ubiquitin–proteas
of CDK14. HEK-293T cells were transfected with the indicated plasmids, cell lysates were
immunoprecipitates with anti-Myc antibody were used for analysis of CCNY phosphory
transfection, whole-cell extracts were prepared and treated with kPP before IB. (D)
transfected as indicated, and then subjected to CHX-chase assay. CCNY protein level was
was quantiﬁed and normalized to tubulin, then normalized to the t = 0 controls (down pa
immunoprecipitates were blotted with anti-HA antibody for detection of conjugated UbCDK14D256A mutant showed 2-fold reduced phosphorylation of
LRP6 at Ser-1490, a known substrate of the CDK14/CCNY complex
(Fig. 3A) and CCNY (Fig. 3B). Because the D256A mutation did not
affect the CDK14-CCNY interaction based on results from yeast
two-hybrid [9] and co-immunoprecipitation experiments (data
not shown), the reduced phosphorylation by CDK14 of its sub-
strates may be due primarily to its reduced kinase activity.
We found that the endogenous level of CCNY decreased upon
the overexpression of wild type CDK14 (Fig. 3C). CHX-chase analy-
sis also showed that the wild type CDK14 promoted CCNY degrada-
tion (Fig. 3D). This CDK14-promoted CCNY degradation was
inhibited by treatment with MG132, a proteasome inhibitor, sug-
gesting the involvement of the proteasome pathway in the regula-
tion of CCNY turnover. We further examined whether CDK14
affected the polyubiquitination of CCNY. The poly-ubiquitination
of CCNY-Myc was greatly increased upon co-expression of CDK14
(Fig. 3E). In contrast with wild-type CDK14, the CDK14D256A
mutant showed much less effect on CCNY degradation. Thus the
CDK14 kinase activity facilitates CCNY degradation through the
ubiquitin–proteasome pathway.
3.4. CDK14 induces SCF-dependent ubiquitination and degradation
of CCNY
Phosphorylation is a common degradation signal for SCF sub-
strates. To determine whether CCNY degradation is mediated by
the SCF complex, we employed RNA interference against Cul1, a
scaffold of the SCF complex. Knockdown of the endogenous Cul1
up-regulated the CCNY protein level in HEK-293T cells (Fig. 4A).
Ectopic expression of Cul1 down-regulated the level of CCNY pro-
tein, whereas ectopic expression of a dominant-negative interfer-
ing mutant of cul1 (DNCul1) [32,33] had a subtle effect on the
reduction of CCNY protein level (Fig. 4B). In a CHX-chase assay,
co-expression of the Cul1 with CCNY promoted CCNY turnover,
whereas co-expression of the DNCul1 extended the half-life ofome pathway. (A and B) The D256A mutation in CDK14 impaired the kinase activity
subjected to immunoblotting analysis for detection of LRP6 phosphorylation (A), and
lation (B). (C) Over-expression of CDK14 reduced CCNY protein level. At 48 h post-
Co-expression of CDK14 promoted CCNY protein turnover. HEK-293T cells were
analyzed by immunoblotting with anti-Myc antibody (up panels), the band intensity
nels). (E) Ectopic expression of CDK14 enhanced CCNY polyubiquitination. Anti-Myc
iquitin moieties.
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ligase is involved in regulation of CCNY degradation.
We further examined the effect of CDK14 on Cul1-mediated
CCNY degradation. CCNY-Cul1 association was signiﬁcantly
enhanced upon ectopic expression of wild-type CDK14 but not of
CDK14D256A mutant (Fig. 4D). The enhancement of CCNY-Cul1
association by CDK14 was greatly reduced by phosphatase treat-
ment (data not shown), suggesting that the CDK14-driven phos-
phorylation facilitates the binding of CCNY to the SCF complex.
In HEK 293T cells, ectopic expression of Cul1 increased the
CDK14-driven degradation of endogenous CCNY, whereas ectopic
expression of DNCul1 stabilized CCNY even in the presence of
CDK14 (Fig. 4E). Thus CDK14 induced CCNY degradation in an
SCF-dependent manner.
3.5. Phosphorylation of CCNY at Ser 71 and Ser 73 by CDK14 triggers
the proteasomal degradation of CCNY
Because multiple residues of CCNY are phosphorylated in vivo,
to determine which ones are phosphorylated directly by CDK14,Fig. 4. SCF complex mediates CDK14-driven proteolysis of CCNY. (A) Knocking-down of
subjected to IB analysis with anti-CCNY or anti-Cullin1 antibody. (B) Transient expression
in HEK-293T cells. The cell lysates were blotted with anti-CCNY antibody. (C) CCNY-My
chase assay. (D) Effect of CDK14 on CCNY-Cul1 interaction. HEK-293T cells transfected
antibody and blotted with anti-Flag or anti-Myc antibody. (E) Effect of Cul1 on CDK14-dr
48 h post-transfection, whole-cell extracts were treated with kPP and blotted with anti-we performed an in vitro kinase assay using bacterially expressed
GST-CCNY and HEK293T-expressed GST-CDK14 (Fig. 5A). The
kinase reaction products were puriﬁed and analyzed by mass spec-
trometry. Several residues of CCNY including Thr-67, Ser-71, Ser-
73, Ser-83, Ser-288, Ser-295 and Ser-326 were identiﬁed to be
phosphorylated (Fig. 5B). All of these sites were included in the
in vivo experiments shown in Fig. 1F. To eliminate the false results
caused by contaminating protein kinases unrelated to CDK14 in
HEK293T cells, we constructed a CDK14 D256A/F176D mutant, a
CDK14 catalytically inactive form, harboring an Asp to Ala muta-
tion at 256 and a deletion of the phenylalanine in the PFTAIRE
motif which is required for binding with cyclin [9] for mapping
CDK14 phosphorylation sites. Immunoblotting results supported
the kinase activity deﬁciency of the D256A/F176Dmutant on CCNY
(Fig. 5A). When the GST-CCNY was incubated with HEK293T-puri-
ﬁed GST-CDK14 D256A/F176D mutant, phosphorylation on Ser-
326 was detected by LC-MS/MS mass spectrometry analysis
(Fig. 5B). Thus Ser-326 phosphorylation is CDK14-independent.
To determine which phosphorylation sites contribute to
the CDK14-driven CCNY ubiquitination and degradation, weCul1 in HEK-293T cells. Cells transfected with Cul1 siRNA oligos, harvested at 48 h,
of wild-type Cul1 and a dominant-negative mutant of Cul1 (Cul11-452aa, DNCul1)
c was co-expressed with Cul1 or DNCu11 in HEK-293T cells and subjected to CHX-
with the indicated plasmids, cell lysates were immunoprecipitated with anti-Myc
iven CCNY degradation. HEK-293T cells transfected with the indicated plasmids. At
CCNY antibody.
Fig. 5. Identiﬁcation of the phosphorylation sites on CCNY contributing to CDK14-driven ubiquitination and degradation. (A) CDK14 phosphorylated CCNY in vitro. GST-
CDK14 or GST-CDK14 D256A/F176D mutant were transfected into HEK-293T cells, GST pulled down proteins were used to phosphorylate bacterially puriﬁed GST-CCNY
in vitro. Kinase reaction products were immunoblotted with anti-phosphoserine antibody. (B) An in vitro mapping of CCNY phosphorylation sites by mass spectrometry
analysis. Phosphorylated peptides and residues by wild-type CDK14 (WT) or D256A/F176Dmutant were summarized and listed in the table. (C) Ser to Ala mutation at residue
71 or 73 reduced the association of CCNY with Cul1. BA: S71A/S73A. (D) Ser to Ala mutation decreased the CDK14-driven ubiquitination of CCNY. (E) Ser to Glu mutation
increased the CCNY ubiquitination. BE: S71E/S73E. (F) S71A/S73A (BA) mutant enhanced CDK14 kinase activity. HEK-293T cells transfected with the indicated plasmids were
arrested at G2/M phase. Whole-cell extracts were blotted with anti-LRP6 (pSer1490) or anti-LRP6 antibody. (G) Sequence alignment around the CCNY phosphorylation sites of
several eumetazoan species. Residues highlighted in black are identical to the human CCNY.
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phosphorylated. Among these sites, the Ser to Ala mutation at 73
showed the strongest defect on CDK14 induced Cul1-association
(Fig. 5C) and poly-ubiquitination (Fig. 5D). CCNY S71A mutation
is also defective on the CDK14-mediated events, whereas the other
single mutation exhibited subtle effects on CDK14-driven ubiquiti-
nation and Cul1-association, suggesting that phosphorylation on
Ser-71 or Ser-73 is critical for SCF-mediated regulation. We next
replaced serine 71 or 73 with phosphomimetic glutamate to mimic
the phosphoresidues. As expected, both single and double Ser to
Glu mutants enhanced CCNY ubiquitination even without co-
expressing CDK14 (Fig. 5E). We further substituted both serine res-
idues at 71 and 73 to alanine. This CCNY double mutant (S71A/
S73A) exhibited greater resistance to CDK14-promoted Cul1-
association and ubiquitination (Fig. 5C and D), more stability than
wild-type CCNY (data not shown), and higher activity on CDK14
catalyzed LRP6 phosphorylation (Fig. 5F). We suggest that phos-
phorylation of CCNY at Ser 71 and Ser 73 by CDK14 may create a
phospho-degron to mediate Cul1-depedent CCNY ubiquitination
and degradation.4. Discussion
In the present study, we investigated the molecular mechanism
underlying regulation of cyclin Y (CCNY) phosphorylation and deg-
radation. The membrane-tethered CCNY interacts with its partner
kinase CDK14 and recruits the CDK14 to the plasma membrane.
After binding to and activating CDK14, the CCNY is in turn phos-
phorylated by CDK14. Then the phosphorylated CCNY is degraded
via a SCF-mediated ubiquitin–proteasome pathway. Thus, the
CDK14 kinase is turned off through negative feedback regulation.
Cyclin Y is synthesized and degraded in a cyclic fashion [3], in
that the phosphorylation and degradation of the cyclin Y is regu-
lated in a pattern that matched the cell cycle. The cyclic pattern
of cyclin Y expression results in the maximum kinase activity of
cyclin Y/CDK14 exhibited in the phosphorylation of LRP6 at
Ser1490 during the G2/M phase [3]. The stabilized CCNY S71/73A
mutant is more capable of activating CDK14 on phosphorylation
of the LRP6 S1490 than wild-type CCNY, linking CCNY turnover
to the induction of Wnt signaling. Autoregulation of the CCNY/
CDK14 complex which acts in CDK14 activation and CCNY
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orchestration of mitotic programs.
Cyclin Y contains a single cyclin-box with long ﬂanking
extensions which have been found to be heavily phosphorylated.
We found that at least six residues were phosphorylated by its
partner kinase CDK14. Interestingly, the CDK14 mediated phos-
phorylation sites in CCNY seem to be conserved among vertebrates,
but not in all eumetazoans (Fig. 5G), reﬂecting a relatively late evo-
lutionary event for autoregulation of the Cyclin/CDK pair. In addi-
tion to the CDK14-dependent phosphorylation sites, a CDK14-
independent phosphorylation site, Ser326, is conserved within
cyclin Y across the animal kingdom. Serine to alanine mutation
of the corresponding residue of fruit ﬂy CCNY results in a CCNY
variant that is unable to bind to Eip63E, the ﬂy ortholog of
CDK14 [2]. Our recently published data demonstrated that phos-
phorylation of human CCNY at Ser326 provides a docking site for
14-3-3 protein binding [34]. Binding of 14-3-3 in turn enhances
the association between CCNY and CDK14. Serine to alanine muta-
tion at residue 326 weakened the CCNY-CDK14 binding afﬁnity
enhanced by 14-3-3 proteins, but did not block the interaction
between CCNY and CDK14. Our data suggest that phosphorylation
of the human CCNY at different sites contributes to its regulation
corresponding to different cellular processes.
Davidson et al. reported that CCNY is ubiquitinated when
ectopically expressed in HEK293 cells [3]. They mainly detected
mono- and di-ubiquitination of FLAG-CCNY, and showed that nei-
ther CCNY levels nor ubiquitination change upon CDK14 co-
expression. In this study, we report that phosphorylation of CCNY
by CDK14 induces its poly-ubiquitination and triggers its degrada-
tion. The discrepancy between our results and those published by
Davidson et al. may be due to the different subcellular distribu-
tion and the phosphorylation state of CCNY, since we used a C-ter-
minal Myc tagged CCNY (CCNY-Myc) for the ubiquitination assay
and Davidson used an N-terminal FLAG tagged CCNY (FLAG-CCNY)
for the assay. As we proved previously, the CCNY is targeted to the
plasma membrane via an N-terminal myristoylation signal [9].
Mutation of glycine to alanine at position 2 or inactivation of
the N-terminal myristoylation signal by fusing a tag in its N-ter-
minus changed its membrane localization, and resulted in CCNY
distributed in cytoplasm or nucleus. C-terminal tagged CCNY
(CCNY-Myc) localized to the plasma membrane, whereas N-termi-
nal tagged CCNY (HA-CCNY) or G2A mutant localized to cyto-
plasm or nucleus. In HEK293 cells, the membrane-associated
CCNY (CCNY-Myc) but not the cytoplasmic localized CCNY (HA-
CCNY) can be phosphorylated and the phosphorylation is
enhanced by CDK14 co-expression (with anti-Phospho-Serine
antibody) [9]. We speculate that FLAG-CCNY may be a non-mem-
brane-associated form, like the HA-CCNY, have a phosphorylation
or ubiquitination state different from that of membrane-associ-
ated CCNY-Myc. It seems that only membrane-associated CCNY
is hyper-phosphorylated, phosphorylation of CCNY at Ser-71 and
Ser-73 by CDK14 triggers its interaction with SCF complex, and
subsequent ubiquitination and degradation in vivo. In addition
to the CDK14 induced SCF dependent pathway, the other path-
ways may be also involved in CCNY degradation, since neither
CDK14 knocking down nor DNCul1 co-expression could com-
pletely inhibit the CCNY degradation, mutation of the putative
phospho-degron (S71A/S73A) could not completely inhibit the
CCNY degradation either. Our unpublished data also suggest that
APC/C complex may be involved in the regulation of CCNY ubiqui-
tination. Thus the CCNY phosphorylation, ubiquitination and deg-
radation should be coordinatively regulated during cellular
processes. Temporal and spatial control of CCNY expression and
degradation may be tightly linked to its function.Acknowledgements
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